Pfizer registers Phase 3 marstacimab hemophilia trial and elranatamab myeloma comparison studyNov 12Weekly roundup, 10 itemsabrocitinibberobenatide
Pfizer adds second Phase 3 berobenatide knee osteoarthritis trial, completes Phase 2b VESPER-3Nov 6Weekly roundup, 13 itemsberobenatidemarstacimab-hncqUpdated
Pfizer registers real-world observational study of marstacimab in hemophilia A and B patientsOct 9Weekly roundup, 8 itemsabrocitinibcyclophosphamide
Pfizer posts hemophilia results, opens eczema Phase 3, ends two skin studies earlyAug 14Weekly roundup, 6 itemsmarstacimab-hncqPF-06823859